Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio

Summary by Bluefield Daily Telegraph
ESTERO, FL / ACCESS Newswire / May 7, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that it will effect a one-for-thirty (1:30) reverse stock split…

2 Articles

Bluefield Daily TelegraphBluefield Daily Telegraph
Lean Left

Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio

ESTERO, FL / ACCESS Newswire / May 7, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that it will effect a one-for-thirty (1:30) reverse stock split…

Read Full Article
stocktitan.netstocktitan.net

Nasdaq compliance push: Aspire Biopharma enacts 1-for-30 split

Post-split trading begins May 11 under ASBP as the company moves to meet Nasdaq's minimum bid price rule; options and warrants adjust too.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news on Thursday, May 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Estero icon

Estero

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal